CJC-1295 without DAC 2mg / vial

01 Overview

The biggest proven advantage of Cjc-1295 Without Dac is that it can biologically conjugate with albumin's serum which has impact on its effective half-life period and therapeutic range.

02 Details

 

CJC – 1295 Without Dac Lyophilized White Powder Releasing Hormone Peptides For Fat Burning

 

 

CJC-1295 Without Dac

CAS:87616-84-0

MF:C152H252N44O42

MW:3367.2

Purity (HPLC):98%

Appearance: White powder

 

The biggest proven advantage of Cjc-1295 Without Dac is that it can biologically conjugate with albumin’s serum which has impact on its effective half-life period and therapeutic range.

Moreover this synthetic drug of proteins’ class can effectively stimulate the pituitary gland therefore making them to produce larger amount of hormone of growth. The main characteristic of this research compound is increasing peptides synthesis which causes rapid growth of muscles.

 

How to use CJC-1295

 

CJC 1295 is typically provided in vials containing 2 or 5 mg of lyophylized powder, though the amount can vary. The contents should be reconstituted by adding a convenient amount of sterile or bacteriostatic water. If for example 2 mL is chosen and the dosing of the vial is 2 mg, the resulting solution then has a concentration of 1 mg/mL, or 1000 mcg/mL.

 

At time of dosing, an insulin syringe is used to draw and then inject the desired amount. In the above example, a 1000 mcg dose would require a volume of 1 mL, or “100 IU” as marked on an insulin syringe.

 

Injection may be subcutaneous, intramuscular, or intravenous according to personal preference. If desired, peptide solutions from other vials, such as a vial of a GHRP product, may also be drawn into the same syringe, if there is room. This reduces the total number of injections required.

 

When recommending CJC 1295, I ordinarily recommend a dosage of 1000 mcg at a time, twice per week.

 

Combined use of CJC-1295 and a GHRP

 

As with Mod GRF, CJC-1295 use can be combined with use of GHRP, but if using a GHRP, for superior results I recommend combining Mod GRF with it rather than CJC-1295.

 

The most important reason for this is observed results. The principal cause of it is that the DAC modification results in relatively lower levels of free peptide. In and of itself, this would be a bad thing, but it’s counterbalanced by the lower levels being sustained. However, if creating peaks with a GHRP, it’s more efficient to have higher levels of free GHRH peptide in, so to speak, “lock step” with those peaks. Mod GRF does this, while CJC-1925 does not.

 

If choosing CJC-1295 anyway to stack with a GHRP, dosing of the CJC-1295 remains as recommended above, while GHRP dosing will be typically 100 mcg at a time, or 50 mcg at a time if using hexarelin.

 

Conclusion

 

For maximal effect in increasing GH production, rather than CJC-1295 I recommend Mod GRF 1-29 in combination with a GHRP, but for support of natural GH production CJC-1295 can provide a convenient solution with injection frequency of only twice weekly. Many have been pleased with the results from CJC-1295 use in bodybuilding, performance enhancement, and “quality of life” applications.

 

DAC or no DAC ?

 

As I have just stated above, when a person sees the term CJC 1295 without DAC this is really means that they are looking at MOD GRF 1-29.  This tetrasubstitued peptide is a modified version of the original GRF 1-29 peptide better known as Semorelin.  Due to the extreme short half life of the original GRF 1-29, chemists were able to modify the peptide to offer a longer biological activity that reduced the metabolic clearance.   Although with MOD GRF 1-29 its modification had resulted in a greater peptide bond, the average user will still likely need to inject two to three times a day with a GHRP to get the maximum effectiveness for releasing endogenous growth hormone.  Now when the drug affinity complex (DAC) was added to CJC 1295, it allowed for an even greater possibility to utilize smaller GH pulses (what was once thought of as a bleed) that, when combined with a GHRP, will activate growth hormone stores to release throughout the day and night.  When the DAC component was added, this allowed the peptide half-life to be extended to about one week and also provided for steadier blood levels after injection.   Now that we understand how important the DAC factor is, this becomes a much more viable and cost effective way to utilize CJC 1295 with DAC along with a GHRP.  The DAC, when added, is able to bind to albumin that circulates the body, literally being able to last for days as it looks for receptors to bind to.  So, in short, if you prefer to use shorter spikes of GH release then the use of the MOD GRF 1-29 (CJC 1295 without DAC) is going to be optimal.  However, if your prefer fewer injections and still want to unleash your growth hormone stores, then 2-3 times a week injections of CJC 1295 with DAC along with your daily injection of GHRP would be the way to proceed for maximizing growth hormone release

 

 

Company Introduction:

(1) High Quality:Wuhan Wang Lianshang Biotechnology Co., Ltd. is a steroids manufacturer with its own lab and factory.
The purity of our product is tested by our quality department before it is shipped to our clients. Mostly steroids are 99% purity and approved by SGS,CTI and ITS.

(2) Favorable Price:Our price meets international market performance and we give the best doiscounted price for our new customers and promotioned price for our regular customers.

(3) Safe Fast Delivery:After receiving your payment,we will have professional package team to arrange your parcel within 12 hours.We can guarantee every goods can be successfully deliveried

(4) Available Shipment Way:EMS,HongKong Post,DHL,TNT,UPS,FedEx,Registered Mail,Air Express,Sea Vessel etc

(5) After-Sale Service:We can offer you good service after you place an order.At the same time,we can offer you some homebrew recipe to make injection.More service is more available to you.

Order Enquiry

  • 6 + 94 =

03 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *